Andreas holds Master Degrees in History, Theology and Philosophy from University of Osnabruck, as well as a business administration degree. Andreas joined Johnson & Johnson in 2000 as Sales Director, Psychiatry at Janssen-Cilag Germany. In 2003, Andreas was appointed to the position of Director, Psychiatry […]
In 1985, Bart joined Janssen Pharmaceutica as a clinical trial monitor. In the course of his career with Janssen, Bart has held a variety of marketing and sales positions, both at local operating company level (e.g. the Netherlands) and at international level. While […]
Johan is currently Director Market Access RWE Partnerships at Janssen and part of its global RWE leadership team. In his current role Johan is coordinating efforts of developing close collaborations between Janssen and other parties in RWE research. Furthermore, Johan […]
Duane Schulthess is the CEO of Vital Transformation, an economics consultancy based in Brussels, Belgium and Washington, DC, focusing on healthcare and biopharma sectors. He has been a member of the U.S. Congressional Health Care Task Force, working closely with regulators, multi-national corporations, governments, and stakeholder […]
Author of more than 130 articles in ISI-indexed journals. Coordinator of nine EU-funded initiatives, […]
Andrew is currently Vice President and Head of Real World Evidence at GSK and is a renowned expert in epidemiological research with specific interest in the utilisation of routine data for research purposes. He acts as an advisor to a number […]
Dipak Kalra plays a leading international role in research and development of Electronic Health Record architectures and systems, including the requirements and models needed to ensure the robust long-term preservation of clinical meaning and protection of privacy. He leads the development of CEN (European Committee for Standardization) […]
A former UK NHS healthcare & voluntary sector professional working in the pharmaceutical and diagnostics industry with a 360° experience in the blood borne virus market based on a professional heritage in the viral hepatitis, liver disease & HIV […]
Dr. Herings is the Scientific Director and a founder of the PHARMO Institute. He is trained as pharmacist, holds a PhD in pharmacoepidemiology from Utrecht University and is specialized in the design, governance, implementation and analyses of large research database networks detailing the use of pharmaceuticals and […]
